多囊卵巢综合征高雄激素血症病因及病理生理机制研究进展

王金凤; 赵一依; 钟甲山; 毕芳芳

doi:10.19538/j.fk2026010125

PDF(992 KB)

中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (1) : 120-123. DOI: 10.19538/j.fk2026010125

综述与讲座

多囊卵巢综合征高雄激素血症病因及病理生理机制研究进展

作者信息 +

文章历史 +

导出引用

王金凤, 赵一依, 钟甲山, 等. 多囊卵巢综合征高雄激素血症病因及病理生理机制研究进展[J]. 中国实用妇科与产科杂志. 2026, 42(1): 120-123 https://doi.org/10.19538/j.fk2026010125

中图分类号： R11.6

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

[1]	Cai M, Ni Z, Yuan Z, et al. Past and present:a bibliometric study on polycystic ovary syndrome[J]. J Ovarian Res, 2023, 16(1):42. DOI:10.1186/s13048-022-01072-3. 本文引用 [1]

[2]	Peña AS, Codner E, Witchel S. Criteria for diagnosis of polycystic ovary syndrome during adolescence:literature review[J]. Diagnostics (Basel), 2022, 12(8):1931. DOI:10.3390/diagnostics12081931. 本文引用 [1]

[3]	Bizuneh AD, Joham AE, Teede H, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome:a systematic review and diagnostic meta-analysis to inform evidence-based guidelines[J]. Hum Reprod Update, 2025, 31(1):48-63. DOI:10.1093/humupd/dmae028. 本文引用 [1]

[4]	Pace L, Kummer N, Wallace M, et al. The value of androgen measures for diagnosing polycystic ovary syndrome (PCOS) in an unselected population[J]. Reprod Sci, 2025, 32(1):168-175. DOI:10.1007/s43032-024-01702-9. 本文引用 [1]

[5]	朱琴玲, 孙贇. 多囊卵巢综合征内分泌异常的诊治[J]. 中国实用妇科与产科杂志, 2024, 40(6):608-614. DOI:10.19538/j.fk2024060109. 本文引用 [1]

[6]	Li Y, Zhai Y, Li L, et al. Divergent associations between serum androgens and ovarian reserve markers revealed in patients with polycystic ovary syndrome[J]. Front Endocrinol(Lausanne), 2022,13:881740. DOI:10.3389/fendo.2022.88174. 本文引用 [1]

[7]	Cussen L, McDonnell T, Bennett G, et al. Approach to androgen excess in women: Clinical and biochemical insights[J]. Clin Endocrinol(Oxf), 2022, 97(2):174-186. DOI:10.1111/cen.14710. 本文引用 [1]

[8]	Chappell NR, Gibbons WE, Blesson CS. Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome[J]. Steroids, 2022,180:108989. DOI:10.1016/j.steroids.2022.108989. 本文引用 [1]

[9]	潘美竹, 张颐. 青春期多囊卵巢综合征患者生活方式的干预对提高生活质量的影响[J]. 中国实用妇科与产科杂志, 2022, 38 (8): 859-861. DOI:10.19538/j.fk2022080123. 本文引用 [2]

[10]	Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease[J]. J Clin Endocrinol Metab, 1980, 50(1):113-116. DOI:10.1210/jcem-50-1-113. 本文引用 [1]

[11]	Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004, 19(1):41-47. DOI:10.1093/humrep/deh098. 本文引用 [2]

[12]	Wang T, Zhang Z, Qu C, et al. Core fucosylation regulates the ovarian response via FSH receptor during follicular development[J]. J Adv Res, 2025, 67:105-120. DOI:10.1016/j.jare.2024.01.025. 本文引用 [1]

[13]	Fiorentino G, Cimadomo D, Innocenti F, et al. Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation:implications for fertility[J]. Hum Reprod Update, 2023, 29(1):1-23. DOI:10.1093/humupd/dmac031. 本文引用 [1]

[14]	Barnes RB. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies[J]. J Endocrinol Invest, 1998, 21(9):567-579. DOI:10.1007/BF03350782. 本文引用 [1]

[15]	Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol signaling at the heart of folliculogenesis:its potential deregulation in human ovarian pathologies[J]. Int J Mol Sci, 2022, 23(1):512. DOI:10.3390/ijms23010512. 本文引用 [1]

[16]	Balen A. The pathophysiology of polycystic ovary syndrome:trying to understand PCOS and its endocrinology[J]. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5):685-706. 本文引用 [1]

[17]	陈咏, 肖玉红, 张倩, 等. 基础窦状卵泡计数对多囊卵巢综合征患者辅助生殖技术后妊娠结局的影响[J]. 中国实用妇科与产科杂志, 2024, 40(11):1125-1129. DOI:10.19538/j.fk2024110115. 本文引用 [1]

[18]	Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance,independent of obesity,in polycystic ovary syndrome[J]. Diabetes, 1989, 38(9):1165-1174. DOI:10.2337/diab.38.9.1165. 本文引用 [1]

[19]	Salley KE, Wickham EP, Cheang KI, et al. Glucose intolerance in polycystic ovary syndrome--a position statement of the androgen excess society[J]. J Clin Endocrinol Metab, 2007, 92(12):4546-4556. DOI:10.1210/jc.2007-1549. 本文引用 [1]

[20]	Feng C, Jin Z, Sun L, et al. Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells[J]. Mol Biol Rep, 2019, 46(5):4953-4965. DOI:10.1007/s11033-019-04946-w. 本文引用 [1]

[21]

Taghibiglou

, Rashid-Kolvear

, Van Iderstine

, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance[J]. J Biol Chem, 2002, 277(1):793-803. DOI:10.1074/jbc.M106737200.

本文引用 [1]

[22]	Horvath TL, Garcia-Segura LM, Naftolin F. Control of gonadotropin feedback: the possible role of estrogen-induced hypothalamic synaptic plasticity[J]. Gynecol Endocrinol, 1997, 11(2):139-143. DOI:10.3109/09513599709152525. 本文引用 [1]

[23]	Yurtdaş G, Akdevelioğlu Y. A new approach to polycystic ovary syndrome: the gut microbiota[J]. J Am Coll Nutr, 2020, 39(4):371-382. DOI:10.1080/07315724.2019.1657515. 本文引用 [1]

[24]	朱依敏. 不孕症合并代谢综合征的孕前管理[J]. 中国实用妇科与产科杂志, 2024, 40(6):604-608. DOI:10.19538/j.fk2024060108. 本文引用 [1]

[25]	邱琳, 刘姜伶, 莫蕙, 等. 定坤丹联合屈螺酮炔雌醇片(Ⅱ)治疗多囊卵巢综合征的有效性及安全性:一项开放标签、非随机对照临床研究[J]. 中国实用妇科与产科杂志, 2025, 41(2):234-240. DOI:10.19538/j.fk2025020117. 本文引用 [1]

[26]	叶生琴, 薛原, 赵晨宇, 等. 广东地区不同表型多囊卵巢综合征患者临床特点及代谢特征分析[J]. 中国实用妇科与产科杂志, 2022, 38(10):1020-1023. DOI:10.19538/j.fk2022100115. 本文引用 [1]

[27]	罗璐, 周灿权. 重视控制性卵巢刺激方案的个体化选择[J]. 中国实用妇科与产科杂志, 2025, 41(12):153-1156. DOI:10.19538/j.fk2025120101. 本文引用 [1]